A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

August 28, 2028

Study Completion Date

November 17, 2028

Conditions
Obesity
Interventions
DRUG

Cagrilintide

Participants will receive cagrilintide subcutaneously.

DRUG

Semaglutide

Participants will receive semaglutide subcutaneously.

DRUG

Placebo cagrilintide

Participants will receive placebo matched to cagrilintide subcutaneously.

DRUG

Placebo semaglutide

Participants will receive placebo matched to semaglutide subcutaneously.

Trial Locations (35)

1200

Cliniques Universitaires Saint-Luc - Serv Endocrinologie - Diabétologie, Brussels

2650

UZA - UZ Antwerpen - Department of Endocrinology, Edegem

Hvidovre Hospital Endokrinologisk forsknings afsnit 159, Hvidovre

2900

Center for Klinisk Metabolisk Forskning, Hellerup

3000

UZ Leuven - Endocrinology, Leuven

4600

Sjællands Universitetshospital, Køge

6700

Sydvestjysk Sygehus Esbjerg, Esbjerg

7000

CHU Helora - Hôpital de Mons - Site Constantinople, Mons

8200

Aarhus Universitetshospital, Steno Diabetes Center Aarhus, Aarhus

29303

Spartanburg Medical Research, Spartanburg

37620

Holston Medical Group_Bristol, Bristol

40213

L-MARC Research Center, Louisville

63303

StudyMetrix Research LLC, City of Saint Peters

75231

North Texas Endocrine Center, Dallas

91723

Valley Clinical Trials, Covina

94598

Diablo Clinical Research, Inc., Walnut Creek

96814

East West Medical Research Institute_Honolulu, Honolulu

06519

Yale University School Of Medicine, New Haven

V8V 4A1

Dr. M.B. Jones Inc, Victoria

B3H 2Y9

Nova Scotia Health Authority, Halifax

L8L 5G4

Premier Clinical Trial Research Network (PCTRN), Hamilton

G2J 0C4

Alpha Recherche Clinique - Lebourgneuf, Québec

4464-513

Unidade Local De Saude De Matosinhos E.P.E., Senhora Da Hora, Matosinhos

1250-189

APDP - Associação Protectora dos Diabéticos de Portugal, Lisbon

1998-018

CUF Descobertas, Lisbon

Hospital Cuf Descobertas S.A., Lisbon

4200-319

Unidade Local de Saude de Sao Joao E.P.E, Porto

4400-346

Hospital Luz Arrabida, S.A., Vila Nova de Gaia

BS10 5NB

Southmead Hospital, Bristol

CB2 0QQ

Addenbrooke's Hospital_Cambridge, Cambridge

CV2 2DX

WISDEM Centre, Coventry

L9 7AL

University Hospital Aintree, Liverpool

E1 2AJ

Blizard Institute_Royal London Hospital, London

SA2 8PP

Joint Clinical Research Facility - Swansea, Swansea

TA1 5DA

Musgrove Park Hospital, Taunton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY